• Services for Regulatory ATMP Development
    Services for Regulatory ATMP Development

    Living biotherapeutics - Oncolytic viruses - AAV vectors

  • ATMP Biodistribution and Shedding Analysis
    ATMP Biodistribution and Shedding Analysis

    qPCR - CFU determination - Flow cytometry - EliSpot

  • MultiPlex miRNA Biomarker Discovery
    MultiPlex miRNA Biomarker Discovery

    Hydrogel particle-based >65-plex from small samples amounts

  • MultiPlex miRNA Clinical Profiling
    MultiPlex miRNA Clinical Profiling

    Pre-designed & custom >65-plex panels

Accelerō® Bioanalytics GmbH is a certified GLP test facility, and operates in compliance with ICH GCP regulations. Competent authorities approved Accelero´s Biosafety Level S2 laboratories for microbiology, cell culture, and genetic engineering.

 

 

The Accelero team is pleased to welcome you at our websites!

Thank you very much for visiting our internet presentation. Accelero is proud to introduce you the following key features:

  • OECD GLP approved facilities for analytical, non-clinical studies
  • ICH E6 R1 GCP compliant analytical facility for clinical phase 0 to 3 studies
  • Facility approved for handling and cultivation of BSL-2 micro-organisms (bacteria, yeasts)
  • Facility approved for genetic engineering / cloning / analysis of safety level S2 GMOs (bacteria, yeasts, viruses, plants, animals)
  • Approval for the import and analysis of animal by-products from non-EU countries
    (e.g. like U.S.A., China)

 

Accelero offers bioanalytical services for research areas like:

  • Nucleic acid based therapeutics like siRNA, miRNA, aptamers, antisense, immuno modulators, plasmids, etc
  • Advanced Therapy Medicinal Products (ATMP) like (genetically modified) human stem cell-based therapeutics
  • Antibodies and peptide-derived therapeutics
  • Nanocarrier research
  • Innovative and novel antibiotics
  • Genetically modified adenoviral expression vectors

 

Accelero services include, but are not limited to:

  • Pharmacokinetic / toxicokinetic characterization (ELISA, qPCR, immuno qPCR)
  • Biodistribution (qPCR)
  • Biomarker screening on the RNA level (qPCR, microarray) and the protein level (microarray)
  • Cell-based assays e.g. on human PBMCs (ELISA, flow cytometry)
  • Cell proliferation and cytotoxicity assays (flow cytometry)
  • Gene expression assays (RTqPCR)
  • GLP training services (basic courses, in-house trainings)
  • Preclinical consulting services with regards to GLP and bioanalysis
  • Supply chain services e.g. like sample transport and shipping organisation, preparation of clinical kits
  • Immunogenicity assays e.g. like Toll-like receptor mediated immunostimulation, antibody detection assays (ADA)

All analytical methods are developed and validated according to the respective EMA, FDA, and/or ICH guidelines.

 

Please visit our corporate website accelero-bioanalytics.com for further information.

 

Last update of this site: 26-APR-2018